Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Kyla Baker and I will be your conference operator today.

Related Keywords

Boston ,Massachusetts ,United States ,California ,Japan ,Kansas ,China ,Beijing ,Matt Korenberg ,Orwin Asparaginase ,Kyla Baker ,Tavo Espinoza ,Joseph Pantginis ,Dwayne Wright ,Balaji Prasad ,Paul Hadden ,Matt Hewitt ,Simon Latimer ,Craig Hallum ,Todd Davis ,Larry Solow ,Scott Henry ,Matthew Korenberg ,Joe Pantginis ,Ligand Pharmaceuticals Incorporated ,Barclays ,Amgen ,Ligand Pharmaceuticals Inc ,Jazz Pharmaceuticals ,Business Development ,Call Transcript May ,First Quarter ,Investor Relations Simon ,Viking Therapeutics ,Senior Vice President ,Healthcare Royalty Partners ,Jazz Pharmaceutical Rylaze ,Viking Therapeutic ,Todayi M ,Berdazimer Gel ,Investors Day ,